Eilmeldung
RUВ Новой Москве легковой автомобиль наехал на несовершеннолетнегоARترامب يفجر قنبلة سياسية في أنقرة ويهدد بضربات عسكرية لإيران.. والأسواق العالمية تترنحTRİran'dan Hürmüz Boğazı Tehdidi: ABD Saldırısına Karşı Şiddetli KarşılıkARترامب يأمر بشن غارات على خارك ويهدد بتدمير البنية التحتية الإيرانيةKR유럽, 또다시 폭염 예고…스페인·프랑스 남부 이미 40도 웃돌아INTLFIFA World Cup 2026 Quarterfinals: Key Matchups and PredictionsKR줄리아니 국장 브리핑… "VAR 슬로모션 사용 정황상 비정상적 레드카드"BRExcesso de plantas aquáticas cobre lagos em Dourados (MS)DEUniCredit stockt Anteil an Commerzbank auf über 44 Prozent aufGLOBALJim Cramer's Charitable Trust Sells Remaining Arm Holdings SharesRUВ Новой Москве легковой автомобиль наехал на несовершеннолетнегоARترامب يفجر قنبلة سياسية في أنقرة ويهدد بضربات عسكرية لإيران.. والأسواق العالمية تترنحTRİran'dan Hürmüz Boğazı Tehdidi: ABD Saldırısına Karşı Şiddetli KarşılıkARترامب يأمر بشن غارات على خارك ويهدد بتدمير البنية التحتية الإيرانيةKR유럽, 또다시 폭염 예고…스페인·프랑스 남부 이미 40도 웃돌아INTLFIFA World Cup 2026 Quarterfinals: Key Matchups and PredictionsKR줄리아니 국장 브리핑… "VAR 슬로모션 사용 정황상 비정상적 레드카드"BRExcesso de plantas aquáticas cobre lagos em Dourados (MS)DEUniCredit stockt Anteil an Commerzbank auf über 44 Prozent aufGLOBALJim Cramer's Charitable Trust Sells Remaining Arm Holdings Shares
Newsgather
BackChilean Scientists' Hantavirus Antibody Breakthrough Stalled by Funding Issues
Chilean Scientists' Hantavirus Antibody Breakthrough Stalled by Funding Issues
Gesundheit
Economic Times14.05.2026GesundheitIndia

Chilean Scientists' Hantavirus Antibody Breakthrough Stalled by Funding Issues

Andes Hantavirus Treatment Shows Promise in Lab and Animal Studies but Awaits Human Trials

Auf einen Blick

Chilean researchers developed antibodies neutralizing the deadly Andes hantavirus in lab and animal studies, but lack of funding and the Covid-19 pandemic halted progress toward human trials, despite recent outbreaks highlighting the need for a treatment.

KI-generierte Zusammenfassung

Schriftgröße

Chilean researchers developed antibodies neutralizing the deadly Andes hantavirus in lab and animal studies, but lack of funding and the Covid-19 pandemic halted progress toward human trials, despite recent outbreaks highlighting the need for a treatment.

Read the full article on Economic Times

Verwandte Themen

This article was originally published by Economic Times.

Ähnliche Meldungen

Mehr zu diesem ThemaAndes hantavirus